12 Drugs Approved for Primary Care in 2019
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
"It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has." - Author unknown
New drugs were approved for many conditions commonly treated in primary care in all 4 quarters in 2019 - quite a few of them first-in-class or novel in another way: The first liquid solution of colchicine for gout The first generic Advair Diskus inhaler for asthma and COPD A novel weight-loss drug that is the first approved for BMI as low as 25 25 kg/m2 The first generic naloxone spray The first oral GLP-1 receptor agonist and a glucagon nasal spray for hypoglycemiaIn the spirit of the holiday, we highlight 12 of the 2019 FDA approvals to prep primary care clinicians for 2020.
